67 175

Cited 0 times in

Changes in glucose metabolism among recipients with diabetes 1 year after kidney transplant: a multicenter 1-year prospective study

DC Field Value Language
dc.contributor.author김유선-
dc.contributor.author주만기-
dc.date.accessioned2023-08-09T07:09:23Z-
dc.date.available2023-08-09T07:09:23Z-
dc.date.issued2023-06-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/196070-
dc.description.abstractBackground: Diabetes mellitus is a common and crucial metabolic complication in kidney transplantation. It is necessary to analyze the course of glucose metabolism in patients who already have diabetes after receiving a transplant. In this study, we investigated the changes in glucose metabolism after transplantation, and a detailed analysis was performed on some patients whose glycemic status improved. Methods: The multicenter prospective cohort study was conducted between 1 April 2016 and 31 September 2018. Adult patients (aged 20 to 65 years) who received kidney allografts from living or deceased donors were included. Seventy-four subjects with pre-transplant diabetes were followed up for 1 year after kidney transplantation. Diabetes remission was defined as the results of the oral glucose tolerance test performed one year after transplantation and the presence or absence of diabetes medications. After 1-year post-transplant, 74 recipients were divided into the persistent diabetes group (n = 58) and the remission group (n = 16). Multivariable logistic regression was performed to identify clinical factors associated with diabetes remission. Results: Of 74 recipients, 16 (21.6%) showed diabetes remission after 1-year post-transplant. The homeostatic model assessment for insulin resistance numerically increased in both groups throughout the first year after transplantation and significantly increased in the persistent diabetes group. The insulinogenic index (IGI30) value significantly increased only in the remission group, and the IGI30 value remained low in the persistent diabetes group. In univariate analysis, younger age, newly diagnosed diabetes before transplantation, low baseline hemoglobin A1c, and high baseline IGI30 were significantly associated with remission of diabetes. After multivariate analysis, only newly diagnosed diabetes before transplantation and IGI30 at baseline were associated with remission of diabetes (34.00 [1.192-969.84], P = 0.039, and 17.625 [1.412-220.001], P = 0.026, respectively). Conclusion: In conclusion, some kidney recipients with pre-transplant diabetes have diabetes remission 1 year after transplantation. Our prospective study revealed that preserved insulin secretory function and newly diagnosed diabetes at the time of kidney transplantation were favorable factors for which glucose metabolism did not worsen or improve 1 year after kidney transplantation.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherFrontiers Research-
dc.relation.isPartOfFRONTIERS IN ENDOCRINOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAdult-
dc.subject.MESHDiabetes Mellitus* / drug therapy-
dc.subject.MESHGlucose-
dc.subject.MESHHumans-
dc.subject.MESHInsulin / metabolism-
dc.subject.MESHKidney Transplantation*-
dc.subject.MESHPrediabetic State* / drug therapy-
dc.subject.MESHProspective Studies-
dc.titleChanges in glucose metabolism among recipients with diabetes 1 year after kidney transplant: a multicenter 1-year prospective study-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Surgery (외과학교실)-
dc.contributor.googleauthorJun Bae Bang-
dc.contributor.googleauthorChang-Kwon Oh-
dc.contributor.googleauthorYu Seun Kim-
dc.contributor.googleauthorSung Hoon Kim-
dc.contributor.googleauthorHee Chul Yu-
dc.contributor.googleauthorChan-Duck Kim-
dc.contributor.googleauthorMan Ki Ju-
dc.contributor.googleauthorByung Jun So-
dc.contributor.googleauthorSang Ho Lee-
dc.contributor.googleauthorSang Youb Han-
dc.contributor.googleauthorCheol Woong Jung-
dc.contributor.googleauthorJoong Kyung Kim-
dc.contributor.googleauthorHyung Joon Ahn-
dc.contributor.googleauthorSu Hyung Lee-
dc.contributor.googleauthorJa Young Jeon-
dc.identifier.doi10.3389/fendo.2023.1197475-
dc.contributor.localIdA00785-
dc.contributor.localIdA03949-
dc.relation.journalcodeJ03412-
dc.identifier.eissn1664-2392-
dc.identifier.pmid37424863-
dc.subject.keywordglucose tolerance test-
dc.subject.keywordimmunosuppression therapy-
dc.subject.keywordinsulin resistance-
dc.subject.keywordinsulin secretion-
dc.subject.keywordkidney transplantation-
dc.subject.keywordtype 2 diabetes mellitus-
dc.contributor.alternativeNameKim, Yu Seun-
dc.contributor.affiliatedAuthor김유선-
dc.contributor.affiliatedAuthor주만기-
dc.citation.volume14-
dc.citation.startPage1197475-
dc.identifier.bibliographicCitationFRONTIERS IN ENDOCRINOLOGY, Vol.14 : 1197475, 2023-06-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.